Table 1.

Selection of commercial chemical libraries

Library Source Compounds Format Description
Libraries of approved drugs, drug candidates, and drug-like compounds
Phenotypic screening library Selleck Chemicals 3751 10 or 2 mM in DMSO, 10 or 2 mM in H2O Bioactive compounds with identified targets and FDA-approved drugs
FDA-approved and Passed Phase I Drug Library Selleck Chemicals 3355 10 or 2 mM in DMSO, 10 or 2 mM in H2O Drugs that are marketed around the world or have passed clinical phase I
Preclinical/Clinical Compound Library Selleck Chemicals 3081 10 or 2 mM in DMSO, 10 or 2 mM in H2O Preclinical and clinical compounds that are structurally diverse, medicinally active, and cell-permeable
Express-Pick Library Selleck Chemicals 3010 10 mM in DMSO Compounds featuring different core structures and structural diversity
The Spectrum Collection MicroSource Discovery Systems 2560 10 mM in DMSO U.S. and international drugs, drug candidates, and natural products
The Pharmakon Collection MicroSource Discovery Systems 1760 10 mM in DMSO Compounds approved in the United States, Europe, and/or Asia
Prestwick Chemical Library Prestwick Chemical Libraries 1520 10 mM in DMSO Diverse small molecules, 98% of which are approved drugs (FDA, EMA, and other agencies)
U.S. Drug Collection MicroSource Discovery Systems 1360 10 mM in DMSO Compounds that have FDA-approved or reached clinical trials in the United States
LOPAC1280 MilliporeSigma/Sigma-Aldrich 1280 10 mM in DMSO A library of pharmacologically active compounds
Tocriscreen 2.0 Tocris Biosciences 1280 10 mM in DMSO Biologically active compounds covering a wide range of pharmacological targets
SCREEN-WELL FDA Approved Drug Library Enzo 775 10 mM in DMSO FDA-approved drug compounds
SCREEN-WELL ICCB Known Bioactives Library Enzo 472 10 mM in DMSO Biologically active small organic molecules developed in cooperation with the Harvard Institute of Chemistry and Cell Biology (ICCB)
International Drug Collection MicroSource Discovery Systems 400 10 mM in DMSO Compounds that are or have been marketed in Europe and/or Asia but not in the United States
Prestwick Original Molecules Library Prestwick Chemical Libraries 344 10 mM in DMSO Original and exclusive drug-like compounds
Tocris FDA-Approved Drugs Library Tocris Biosciences 190 10 mM in DMSO Selection of FDA-approved drugs
Libraries of inhibitors and target class–specific compounds
Kinase Inhibitor Library Selleck Chemicals 1766 10 or 2 mM in DMSO, 10 or 2 mM in H2O Kinase inhibitors, mostly ATP competitive, some are FDA-approved
GPCR Compounds Library Selleck Chemicals 1273 10 or 2 mM in DMSO, 10 or 2 mM in H2O Compounds targeting G protein–coupled receptors (GPCRs)
Tyrosine Kinase Inhibitor Library Selleck Chemicals 533 10 or 2 mM in DMSO, 10 mM in H2O Tyrosine kinase inhibitors, some are FDA-approved
Cytokine Inhibitor Library Selleck Chemicals 462 10 or 2 mM in DMSO, 10 or 2 mM in H2O Kinase inhibitors mostly ATP-competitive, some are FDA-approved
Prestwick GPCR Drug Library Prestwick Chemical Libraries 265 10 mM in DMSO Approved drugs known to interact primarily with GPCRs
Ion Channel Ligand Library Selleck Chemicals 231 10 or 2 mM in DMSO, 10 or 2 mM in H2O Small-molecule modulators targeting diverse ion channels
Tocrisscreen Kinase Inhibitor Library Tocris Biosciences 160 10 mM in DMSO Compounds targeting >60 different kinases
Inhibitor Library I MilliporeSigma/Sigma-Aldrich 80 10 mM in DMSO Inhibitors against mainly tyrosine, AGC, and atypical families of kinases
Inhibitor Library II MilliporeSigma/Sigma-Aldrich 80 10 mM in DMSO Inhibitors against mainly CMGC and CaMK kinases
Inhibitor Library III MilliporeSigma/Sigma-Aldrich 84 10 mM in DMSO Inhibitors against mainly CMGC, CaMK, AGC, and STE kinases
Inhibitor Library IV MilliporeSigma/Sigma-Aldrich 83 0.5–100 mM in DMSO Inhibitors against mainly tyrosine kinases and tyrosine phosphatases
SCREEN-WELL Kinase Inhibitor Library Enzo 80 10 mM in DMSO Known kinase inhibitors of well-defined activity
SCREEN-WELL Nuclear Receptor Ligand Library Enzo 74 10 mM in DMSO Compounds with defined, putative, and potential activity at nuclear receptors, receptor agonists, and antagonists

This Article

  1. Cold Spring Harb Protoc 2023: pdb.prot098269-